INTERNATIONAL PATENT: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, MAHZI THERAPEUTICS INC. FILES APPLICATION FOR "ANTISENSE OLIGONUCLEOTIDES FOR TREATING PITT HOPKIN SYNDROME"

GENEVA, Oct. 15 -- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER (1124 West Carson StreetTorrance, California 90502), MAHZI THERAPEUTICS INC. (470 Noor Ave, STE B, #1036South San Francisco, California 94080) filed a patent application (PCT/US2025/023257) for "ANTISENSE OLIGONUCLEOTIDES FOR TREATING PITT HOPKIN SYNDROME" on Apr 04, 2025. With publication no. WO/2025/213093, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): IACOVINO, Michelina (c/o Lundquist Institute for Biomedical Innovation at...